Diabetes Bracelets and Wristbands
Show your support for diabetics and diabetes research! Wear a diabetic wristband or bracelet.
Diabetic wristbands and diabetic bracelets can be hard to find, but we hope this
page will be a help to you.
Diabetic Wristbands & Diabetic Bracelets
Please visit our Diabetes Information site.
Diabetic News
Lacosamide Shows Impressive Safety Profile In Painful Diabetic Neuropathy
16 Apr 2008 at 10:00am
Lacosamide is generally safe and well tolerated when used to treat patients with painful diabetic neuropathy, investigators announced here at the 60th Annual Meeting of the American Academy of Neurology (AAN). Lacosamide (LCM) is an anticonvulsant under investigation for its potential effect in decreasing diabetic neuropathic pain.
Proteins in Urine May Predict Diabetic Kidney Disease
30 Jan 2008 at 7:26am
A recent study found that looking at proteins in urine might help doctors
figure out who is more likely to develop the condition called diabetic
nephropathy. Learn more...
Debut issue of Foot & Ankle Specialist
12 Feb 2008 at 10:00pm
Foot infections are common among diabetic patients and are a major cause of hospitalization and amputation. A multidisciplinary surgical and medical team is necessary to adequately treat severe diabetic foot infection.
TAXUS(R) Stent Demonstrates Similar Outcomes In Diabetic Patients Compared To Non Diabetics In Pooled Analysis Of TAXUS IV And V Trials
2 Apr 2008 at 1:00am
Boston Scientific Corporation (NYSE: BSX) announced results from a pooled analysis of patients from its TAXUS IV and TAXUS V randomized clinical trials. The analysis compared the safety and efficacy of the TAXUS(R) Express(TM) Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients.
Will The Real Expert On Curing Diabetes Please Stand Up!
2 Apr 2008 at 3:46am
Charles Masison cured himself of Diabetes despite doctors telling him it was not possible to do so. In his 216 page book, "Winning The Fight Against Diabetes" Charles Masison describes how he was able to bring his Glucose reading down from a diabetic 178 to a non-diabetic 106.
Promising early evidence of the superior benefits of drug therapy for diabetic eye disease
28 Apr 2008 at 10:00pm
A JDRF collaboration between Johns Hopkins researchers and Genentech has shown that a drug for the treatment of diabetic eye disease has performed better in clinical trials than the current standard treatment using laser surgery.
Data Presented At AAN Show That Lacosamide Significantly Reduced Pain And Was Generally Well Tolerated In Patients With Diabetic Neuropathic Pain
17 Apr 2008 at 2:52am
UCB presented efficacy and safety results from pooled analyses of Phase II and III double-blind, randomized, placebo-controlled clinical trials investigating lacosamide for the treatment of diabetic neuropathic pain.
Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
15 Mar 2008 at 10:00pm
Two major eye diseases and leading causes of blindness -- age-related macular degeneration and diabetic retinopathy -- can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.
MacroChem Announces Presentation Of Pexiganan Phase 3 Study Results For Topical Treatment Of Diabetic Foot Infection
14 Mar 2008 at 1:00am
MacroChem Corporation (OTC Bulletin Board: MACM) announced the presentation of a poster entitled "Topical versus Systemic Antimicrobial Therapy for Treating Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double-Blinded, Multicenter Trial of Pexiganan Cream.
ArthroCare(R) Sports Medicine To Tackle Diabetic Foot Ulcers
28 Mar 2008 at 4:00pm
As part of ArthroCare Sports Medicine's recent entry into the Foot and Ankle arena, ArthroCare(R) Corp. (Nasdaq: ARTC) announced today that it has launched early stage clinical and pre-clinical research work for treating diabetic foot ulcers and is encouraged by preliminary results reported by physicians.
Moran Eye Center researchers find gene linked to severe diabetic eye and kidney diseases
4 May 2008 at 10:00pm
Researchers at the John A. Moran Eye Center at the University of Utah and collaborative institutions have identified a gene called erythropoietin that contributes to increased risk of severe diabetic eye and kidney diseases, called retinopathy and nephropathy.
Novagali Pharma Successfully Enrolls First Patient In U.S. Phase I Clinical Study With CORTIJECT(R) For Diabetic Macular Edema
25 Apr 2008 at 2:47am
Novagali Pharma, an emerging ophthalmic pharmaceutical company announced that it has successfully injected the first patient in a Phase I clinical trial using CORTIJECT(R), an ophthalmic injectable emulsion based on EYEJECT(R) technology platform containing a corticosteroid prodrug for the treatment of Diabetic Macular Edema (DME).
Final Study Results Show V.A.C.(R) Therapy To Be More Efficacious Than Advanced Moist Wound Therapy In Treating Diabetic Foot Ulcers
13 Feb 2008 at 2:00am
Kinetic Concepts, Inc. (NYSE:KCI) announced the final efficacy results of a randomized controlled clinical trial (RCT) on the clinical efficacy of KCI's V.A.C.(R) System negative pressure wound therapy (NPWT) compared to advanced moist wound therapy (AMWT) to treat diabetic patients with foot ulcers. The study, which showed that V.A.C.
Oramed Pharmaceuticals Granted Approval To Conduct Phase 2A Trials Of Its Oral Insulin Capsule
19 Mar 2008 at 3:51am
Oramed Pharmaceuticals Inc. has been granted approval by the Institutional Review Board (IRB) committee of Hadassah Medical Center in Jerusalem to conduct a Phase 2A study of its oral insulin on diabetic volunteers. This Phase 2A study is designed to evaluate the safety and efficacy of Oramed's oral insulin capsule on Type II diabetic volunteers.
Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers For MATRIX Clinical Trial
26 Feb 2008 at 2:49am
Associated Foot & Ankle Specialists announced it is recruiting patients with foot ulcers due to diabetes to participate in the MATRIX clinical trial. The trial will study the effects of a new product, Excellarate, for the potential treatment of patients with non-healing diabetic foot ulcers. Excellarate is an investigational product designed to stimulate the process of wound healing.